RPL17 and neoplasm: Due to this mechanism, the PD-L1/PD-1 axis has been found to be an crucial mechanism by which tumor cells evade T cell immunity, PD-1 inhibitors revitalize CD8+T cells by blocking the PD-1/PD-L1 pathway, promoting their proliferation and functional recovery (42–44).